FSSAI Launches Nationwide Action Against Mislabelled ORS Beverages

 



India’s food safety regulator has taken a decisive step to curb misleading health claims by ordering the removal of beverages falsely marketed as oral rehydration solutions. The directive targets fruit-based drinks, energy drinks and electrolyte beverages that misuse the medically significant term “ORS” without meeting approved standards.

Regulator Targets Misleading Product Labels

The order clarifies that no beverage may use the term “ORS” in its name or branding unless it follows the medically established formulation. Several products were found to contain excessive sugar and flavouring agents, creating a false impression of therapeutic value.

Strict Compliance for Food Business Operators

All manufacturers, retailers and digital platforms must immediately withdraw non-compliant items. Enforcement teams have been instructed to inspect outlets, remove mislabelled drinks and ensure only WHO-standard ORS products remain available.

Consumer Risks Linked to False ORS Claims

The regulator highlights that true ORS requires a precise combination of glucose and essential salts. Drinks that do not meet this standard may worsen dehydration, particularly in children, when used during illness. Misbranding also leads to confusion at point of purchase.

Guidance for Consumers Amid Market Clean-Up

Shoppers are encouraged to read labels carefully and verify electrolyte content before purchase. Experts advise relying on trusted ORS sachets for effective rehydration rather than sweetened beverages. Public reporting of non-compliant products can further support enforcement efforts as markets transition to clearer and safer labelling practices.

#FSSAI #FoodSafety #ORSAlert #MislabelledProducts #ConsumerProtection
#HealthRegulation #FoodStandards #PublicHealthIndia #SafetyCompliance #RegulatoryAction

World Cell Biologist Awards: 

Website Link : cellbiologist.org 

Follow Us On : 
Tumblr ; tumblr.ccom/

Comments

Post a Comment

Popular posts from this blog

Uttrakhand Forest Department Establishes Mahabharata Vatika

Image
  The Uttarakhand Forest Department has established two gardens in Haldwani, showcasing plant species referenced in ancient Indian epics. These gardens, named Ramayana Vatika and Mahabharata Vatika, aim to highlight the ecological wisdom embedded in these texts. Mahabharata Vatika Overview Mahabharata Vatika spans one acre and features 37 plant species mentioned in the epic. Chief Conservator of Forests Sanjeev Chaturvedi emphasised the research behind selecting these species. The garden features important plant species such as: Ecological Significance The garden puts stress on the importance of forests as depicted in the Mahabharata. It references the Vana Parva, which discusses tree planting and wildlife conservation . The epic highlights the mutual dependence of tigers and forests, a concept vital to contemporary conservation efforts. Cultural Connections Chaturvedi brought into light that the Mahabharata teaches the spiritual significance of planting trees. He mentioned Bhish...
Read more

What is Zolgensma?

Image
  Spinal Muscular Atrophy (SMA) is a rare genetic disease affecting muscle function. In India, treatment options are limited, mainly due to high costs. The gene therapy drug, Zolgensma , costs around 16 crore rupees. Despite this, some families are finding ways to access treatment. About Spinal Muscular Atrophy (SMA) SMA is a genetic disorder that leads to the loss of motor neurons in the spinal cord. This results in muscle weakness and atrophy. Symptoms often appear in infancy. Children may struggle with basic movements like lifting their heads or crawling. Early diagnosis is crucial for effective treatment. About Zolgensma Zolgensma (onasemnogene abeparvovec-xioi) is a revolutionary gene therapy for SMA. It addresses the root cause by replacing the missing or defective SMN1 gene . This therapy can improve motor function in affected children. Although it is costly, it represents hope for many families. SMA is not as rare as once thought. The global prevalence is estimated at 1 in ...
Read more

CAR T-Cell Therapy for Cancer

Image
  India has recently made strides in cancer treatment with the introduction of CAR T-cell therapy . The results from the first clinical trials have been published in The Lancet, showcasing a remarkable success rate. This therapy is a game changer for patients with blood cancers. It offers hope to those who have exhausted other treatment options. What is CAR T-Cell Therapy? CAR T-cell therapy, or chimeric antigen receptor T-cell therapy, is an innovative treatment that harnesses the body’s immune system. It trains T-cells to target and destroy cancer cells. This therapy is specifically designed for certain blood cancers. It is particularly beneficial for patients whose cancer has relapsed or failed to respond to standard treatments. Clinical Trial The clinical trials reported a response rate of nearly 73%. This indicates that number of patients benefited from the treatment. The trials also provided critical data on survival rates for patients with acute lymphoblastic leukaemia and l...
Read more